UPDATE: Goldman Sachs Raises Medicis Pharmaceuticals' PT - Marex Group (NASDAQ:MRX)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

According to a research report published earlier today, Goldman Sachs has increased Medicis Pharmaceuticals' (NYSE: MRX) PT from $38 to $41.Goldman Sachs said in the report, “Guidance for 2012, near-term ASP guidance for Solodyn and Ziana, and greater color on the Zyclara strategy left us feeling more comfortable with both the 2012 outlook and the company's longer-term growth strategy. Going forward, the key areas of focus will be understanding the Rx Assist initiative and greater clarity on the growing pipeline. We maintain our Neutral rating, but we have increased our price target.”Medicis Pharmaceuticals is currently trading at $35.60.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!